Severe COVID-19 infection in a patient with a blastic transformation of a chronic myeloid leukemia and severe treatment-induced immunosuppression : a case report
Copyright: Louardi Mounir et al..
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has rapidly spread across the globe, leading to the declaration of a pandemic. While most present mild symptoms, it appears as though nearly 20% of confirmed patients develop significant complications. At this time of uncertainty, we are struggling to provide appropriate care to hematological cancer patients. We need to weigh the risks and benefits of giving cancer treatment against the odds of infecting them with COVID-19. As hematological cancer patients are immunocompromised and there are high chances of exposure during hospital visits, they can get infected and outcome can be fatal. So in this case report, we intend to discuss the possible impact of the current COVID-19 pandemic on patients with acute leukaemia in terms of diagnosis, chemotherapy, and prophylactic measures.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2020 |
---|---|
Erschienen: |
2020 |
Enthalten in: |
Zur Gesamtaufnahme - volume:37 |
---|---|
Enthalten in: |
The Pan African medical journal - 37(2020), Suppl 1 vom: 13., Seite 34 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Mounir, Louardi [VerfasserIn] |
---|
Links: |
---|
Themen: |
---|
Anmerkungen: |
Date Completed 24.02.2021 Date Revised 24.02.2021 published: Electronic-eCollection Citation Status MEDLINE |
---|
doi: |
10.11604/pamj.supp.2020.37.34.25501 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM320192792 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM320192792 | ||
003 | DE-627 | ||
005 | 20231225173046.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2020 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.11604/pamj.supp.2020.37.34.25501 |2 doi | |
028 | 5 | 2 | |a pubmed24n1067.xml |
035 | |a (DE-627)NLM320192792 | ||
035 | |a (NLM)33456658 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Mounir, Louardi |e verfasserin |4 aut | |
245 | 1 | 0 | |a Severe COVID-19 infection in a patient with a blastic transformation of a chronic myeloid leukemia and severe treatment-induced immunosuppression |b a case report |
264 | 1 | |c 2020 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 24.02.2021 | ||
500 | |a Date Revised 24.02.2021 | ||
500 | |a published: Electronic-eCollection | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Copyright: Louardi Mounir et al. | ||
520 | |a The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has rapidly spread across the globe, leading to the declaration of a pandemic. While most present mild symptoms, it appears as though nearly 20% of confirmed patients develop significant complications. At this time of uncertainty, we are struggling to provide appropriate care to hematological cancer patients. We need to weigh the risks and benefits of giving cancer treatment against the odds of infecting them with COVID-19. As hematological cancer patients are immunocompromised and there are high chances of exposure during hospital visits, they can get infected and outcome can be fatal. So in this case report, we intend to discuss the possible impact of the current COVID-19 pandemic on patients with acute leukaemia in terms of diagnosis, chemotherapy, and prophylactic measures | ||
650 | 4 | |a Case Reports | |
650 | 4 | |a Journal Article | |
650 | 4 | |a COVID-19 | |
650 | 4 | |a Leukaemia | |
650 | 4 | |a chemotherapy | |
700 | 1 | |a Mehdi, Simou |e verfasserin |4 aut | |
700 | 1 | |a Kawtar, Fahmaoui |e verfasserin |4 aut | |
700 | 1 | |a Akram, Mansour |e verfasserin |4 aut | |
700 | 1 | |a Youness, Et-Tahir |e verfasserin |4 aut | |
700 | 1 | |a Meryem, Tabat |e verfasserin |4 aut | |
700 | 1 | |a Othmane, Joutey Tahiri |e verfasserin |4 aut | |
700 | 1 | |a Imane, Elkhaouri |e verfasserin |4 aut | |
700 | 1 | |a Hanane, Ezzouine |e verfasserin |4 aut | |
700 | 1 | |a Boubakar, Charra |e verfasserin |4 aut | |
700 | 1 | |a Marieme, Camara |e verfasserin |4 aut | |
700 | 1 | |a Mouna, Lamchahab |e verfasserin |4 aut | |
700 | 1 | |a Asmaa, Harrach |e verfasserin |4 aut | |
700 | 1 | |a Asmaa, Quessar |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t The Pan African medical journal |d 2008 |g 37(2020), Suppl 1 vom: 13., Seite 34 |w (DE-627)NLM20399910X |x 1937-8688 |7 nnns |
773 | 1 | 8 | |g volume:37 |g year:2020 |g number:Suppl 1 |g day:13 |g pages:34 |
856 | 4 | 0 | |u http://dx.doi.org/10.11604/pamj.supp.2020.37.34.25501 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 37 |j 2020 |e Suppl 1 |b 13 |h 34 |